搜索临床试验以:Castrate resistant prostate cancer
总计90744个结果
-
Sandy SrinivasWyeth is now a wholly owned subsidiary of Pfizer; American Society of Clinical Oncology; National...终止
-
AstraZeneca完全的转移性去势抵抗性前列腺癌 (mCRPC), | 功效, | 安全性和耐受性, | 药代动力学, | 药效学, | 肿瘤反应。英国, 美国
-
Tehran University of Medical Sciences完全的
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; Oregon Health and Science University撤销
-
Centocor Research & Development, Inc.完全的
-
Infinity Pharmaceuticals, Inc.完全的
-
British Columbia Cancer AgencyFerring Pharmaceuticals未知
-
Sanofi终止
-
Central Hospital, Nancy, France尚未招聘
-
Canadian Cancer Trials GroupCanadian Institutes of Health Research (CIHR)尚未招聘转移性前列腺癌 | 转移性去势抵抗性前列腺癌
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany尚未招聘
-
Fusion Pharmaceuticals Inc.招聘中
-
AstraZenecaMerck Sharp & Dohme LLC招聘中
-
Mayo Clinic招聘中复发性前列腺癌 | 去势抵抗性前列腺癌 | IVB 期前列腺癌 AJCC v8 | 复发性去势敏感前列腺癌美国
-
The First Affiliated Hospital of Xiamen University招聘中
-
Merck Sharp & Dohme LLCOrion Corporation, Orion Pharma招聘中前列腺肿瘤,去势抵抗以色列, 台湾, 澳大利亚, 大韩民国
-
SL VAXiGEN招聘中
-
University Hospital, Basel, Switzerland尚未招聘
-
Nuvation Bio Inc.招聘中
-
Rohan GarjeJanssen Scientific Affairs, LLC尚未招聘
-
Roswell Park Cancer Institute招聘中
-
Jonsson Comprehensive Cancer CenterNovartis Pharmaceuticals尚未招聘